Compile Data Set for Download or QSAR
maximum 50k data
Found 1683 with Last Name = 'siegrist' and Initial = 'r'
TargetVoltage-dependent T-type calcium channel subunit alpha-1I(Homo sapiens (Human))
Idorsia Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50452245(Act-709478)
Affinity DataKi:  20nMAssay Description:Binding activity to inactivated state of recombinant human Cav3.3 expressed in CHO cells assessed as inhibition of tail current amplitude by whole ce...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189204(US9169270, 76)
Affinity DataIC50:  0.200nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205858(US9255090, 327)
Affinity DataIC50:  0.200nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205626(US9255090, 95)
Affinity DataIC50:  0.220nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205728(US9255090, 197)
Affinity DataIC50:  0.280nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205727(US9255090, 196)
Affinity DataIC50:  0.280nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189192(US9169270, 64)
Affinity DataIC50:  0.300nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205766(US9255090, 235)
Affinity DataIC50:  0.300nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205768(US9255090, 237)
Affinity DataIC50:  0.300nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189201(US9169270, 73)
Affinity DataIC50:  0.300nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189187(US9169270, 59)
Affinity DataIC50:  0.400nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189195(US9169270, 67)
Affinity DataIC50:  0.400nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205714(US9255090, 183)
Affinity DataIC50:  0.460nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205730(US9255090, 199)
Affinity DataIC50:  0.490nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205880(US9255090, 349)
Affinity DataIC50:  0.5nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189199(US9169270, 71)
Affinity DataIC50:  0.5nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189196(US9169270, 68)
Affinity DataIC50:  0.5nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205719(US9255090, 188)
Affinity DataIC50:  0.530nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205861(US9255090, 330)
Affinity DataIC50:  0.600nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189203(US9169270, 75)
Affinity DataIC50:  0.600nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205902(US9255090, 371)
Affinity DataIC50:  0.600nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173248(US9096595, 51)
Affinity DataIC50:  0.600nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205769(US9255090, 238)
Affinity DataIC50:  0.600nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205731(US9255090, 200 | US9255090, 201 | US9255090, 359)
Affinity DataIC50:  0.600nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205763(US9255090, 232)
Affinity DataIC50:  0.600nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205691(US9255090, 160)
Affinity DataIC50:  0.670nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205723(US9255090, 192)
Affinity DataIC50:  0.690nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205965(US9255090, 434)
Affinity DataIC50:  0.700nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205736(US9255090, 205 | US9255090, 206 | US9255090, 229)
Affinity DataIC50:  0.700nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173207(US9096595, 10)
Affinity DataIC50:  0.700nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189194(US9169270, 66)
Affinity DataIC50:  0.700nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205725(US9255090, 194)
Affinity DataIC50:  0.75nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent T-type calcium channel subunit alpha-1I(Homo sapiens (Human))
Idorsia Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50452305(CHEMBL4203847)
Affinity DataIC50:  0.760nMAssay Description:Inhibition of recombinant Cav3.3 (unknown origin) expressed in HEK293 cells assessed as decrease in calcium flux preincubated for 3 mins followed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173229(US9096595, 32)
Affinity DataIC50:  0.800nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205944(US9255090, 413)
Affinity DataIC50:  0.800nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205827(US9255090, 296)
Affinity DataIC50:  0.800nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205921(US9255090, 390)
Affinity DataIC50:  0.800nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205767(US9255090, 236)
Affinity DataIC50:  0.800nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173244(US9096595, 47)
Affinity DataIC50:  0.800nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVoltage-dependent T-type calcium channel subunit alpha-1I(Homo sapiens (Human))
Idorsia Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50452243(CHEMBL4205005)
Affinity DataIC50:  0.890nMAssay Description:Inhibition of recombinant Cav3.3 (unknown origin) expressed in HEK293 cells assessed as decrease in calcium flux preincubated for 3 mins followed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205718(US9255090, 187)
Affinity DataIC50:  0.890nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM189191(US9169270, 63)
Affinity DataIC50:  0.900nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 μl. First, 25 μl of test compound, previously diluted in Binding-Buffer (Binding...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205765(US9255090, 234)
Affinity DataIC50:  0.900nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205715(US9255090, 184)
Affinity DataIC50:  0.900nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205875(US9255090, 344)
Affinity DataIC50:  0.900nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205866(US9255090, 335)
Affinity DataIC50:  0.900nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205855(US9255090, 324)
Affinity DataIC50:  0.900nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM205738(US9255090, 207 | US9255090, 208 | US9255090, 227)
Affinity DataIC50:  0.900nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent T-type calcium channel subunit alpha-1I(Homo sapiens (Human))
Idorsia Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50452246(CHEMBL4216687)
Affinity DataIC50:  0.920nMAssay Description:Inhibition of recombinant Cav3.3 (unknown origin) expressed in HEK293 cells assessed as decrease in calcium flux preincubated for 3 mins followed by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetProstaglandin D2 receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173206(US9096595, 9)
Affinity DataIC50:  1nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 1683 total ) | Next | Last >>
Jump to: